Posted by Michael Wonder on 14 Oct 2020
TGA grants second provisional determination for a COVID-19 vaccine
14 October 2020 - The Therapeutic Goods Administration has granted a provisional determination to Pfizer Australia in relation to its COVID-19 Vaccine, BNT162b2 [mRNA].
The granting of a provisional determination means that the TGA has made a decision that Pfizer is now eligible to apply for provisional registration for the vaccine in the Australian Register of Therapeutic Goods.
